44 2033180199
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Journal of Pharmacology and Medicinal Chemistry

Sign up for email alert when new content gets added: Sign up

Development of versatile biological models to study nanodevices biomedical potential

Joint Event on 4th International Conference on Nanomedicine and Nanotechnology & 4th World Biotechnology CONGRESS

May 20-21, 2019 London, UK

Morgane Daurat

Institut des Biomolecules Max Mousseron, France

Posters & Accepted Abstracts: J Pharmacol Med Cheml

Abstract :

The development of personalized and non-invasive therapies based on new nanoparticles is a major challenge in medicine. In this context, we studied different nanoparticles for cancer therapy.

Firstly, we analyzed the biological efficiency of hollow organosilica nanoparticles. Porous systems are used to be applied to drug adsorption and delivery. In this case, we have loaded two anti-cancer drugs, which have been used to perform in vitro investigations in order to demonstrate their biocompatibility and their potential as drug carrier vehicles to treat cancer.

Moreover, nanoscience has grown considerably in cancer treatment with nanoparticles activated with stimuli as Mn2+-doped Prussian blue nanoparticles. They are many advantages as their flexible structure, porosity and biocompatibility. Indeed, Prussian blue has been approved by the Food and Drug Administration for human. We have demonstrated for the first time that these nanoparticles acted as efficient agents for photothermal therapy under Two-Photon Excitation (TPE) and induce an almost eradication of malignant cells.

Finally, in order to respond to increasing demand for new therapies, the Photo Dynamic Therapy (PDT) has arisen as an alternative to chemo- and radiotherapy for the non-invasive selective destruction of small tumors. PDT is based on photosensitizers activation by irradiation. To enhance the selectivity towards tumor cells and the efficiency of PDT, the photosensitizers are encapsulated in Periodic Mesoporous Organosilica (PMO) nanoparticles. To go further in the biomedical proof of concept of therapeutic nanoparticles, we are currently developing an animal model as Danio rerio (zebrafish) to study cancer. We have implanted fluorescent human cancer cells in zebrafish larvae in order to establish a detectable tumor xenograft. Then, we have intravenously injected PMO for TPE-PDT in zebrafish and irradiated the tumor site with a pulsed laser. The strong decrease in tumor size let us imagine developing such model to test the biomedical potential of different nanoparticles.

Biography :

Morgane Daurat is born in 1991 in Béziers (France). She is a PhD student in third year at Institut des Biomolecules Max Mousseron in Montpellier (France). She works on the development of biological models to study nanoparticles biomedical potential and on lysosomal diseases for the company NanoMedSyn (Montpellier, France). She is co-author of nine articles.

E-mail: morgane.daurat@etu.umontpellier.fr

 
Google Scholar citation report
Citations : 19

Journal of Pharmacology and Medicinal Chemistry received 19 citations as per Google Scholar report

pulsus-health-tech
Top